Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.
Ensure accurate CFU/gm testing for your cell therapy laboratory. Biovault Technical provides reliable and consistent assays, helping you maintain cell quality and focus on your core work.
Discover how Biovault supports oncologists and haematologists with bespoke stem cell processing, storage and logistics services for regenerative cellular therapies.
Following the publication of a report on the devastating cryogenic freezer failure at the Karolinska Institutet (KI) in Sweden in December 2023, we scrutinise our systems and offer some support.
In 2023, Biovault worked alongside 6 NHS trusts to process 1,552 cellular therapy products and to release 753, making us a leading provider of PBSC services.
